-
Mashup Score: 0AWIR National Conference - 13 hour(s) ago
Highlights from the AWIR National Conference, including perspectives and interviews with leading researchers and clinicians.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2‘On the cusp of a new era’: Promising drugs may tackle unmet needs in giant cell arteritis - 15 hour(s) ago
Nearly all rheumatologists who responded to a recent survey reported patients with giant cell arteritis are in dire need of new treatments, according to a market analysis from Spherix Global Insights.The analysis, conducted between Feb. 15 and March 1 among 109 rheumatologists, indicates that 98% of respondents stated there is a “moderate to extremely high” unmet need for new
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0
The FDA has granted fast track designation to a sublingual tablet form of the muscle relaxant cyclobenzaprine hydrochloride for the management of fibromyalgia, according to a press release from the manufacturer. Tonix Pharmaceuticals reported that its patented form of the drug, Tonmya (cyclobenzaprine HCl), received the designation following results of the phase 3 RESILIENT study, which were
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0AWIR National Conference - 1 day(s) ago
Highlights from the AWIR National Conference, including perspectives and interviews with leading researchers and clinicians.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0AWIR National Conference - 2 day(s) ago
Highlights from the AWIR National Conference, including perspectives and interviews with leading researchers and clinicians.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0TNF inhibitors equally safe, effective in young- and late-onset ankylosing spondylitis - 2 day(s) ago
TNF inhibitors have similar rates of adverse events and treatment response in ankylosing spondylitis regardless of whether the disease developed early or late in life, according to data published in Scientific Reports. “It is rare for symptoms [of ankylosing spondylitis] to appear after the age of 45,” Sadettin Uslu, MD, of the division of rheumatology at the Celal Bayar University
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0Training the ‘inner voice to be kind’ critical for young patients with rheumatic diseases - 2 day(s) ago
ORLANDO, Fla. — Cognitive behavioral therapy can help children and adolescents with rheumatic diseases cope with the challenges of their condition, according to a presenter at the 2024 Rheumatology Nurses Society annual conference. “Coping skills are strategies we use to manage feelings and handle stress,” Polly Livermore, PhD, a senior pediatric rheumatology nurse at University
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1‘We try not to limit them’: Striving for normalcy key for children with rheumatic diseases - 3 day(s) ago
ORLANDO, Fla. — Allowing children with rheumatic diseases the time and space to formulate their own thoughts on their condition can facilitate communication and help them live a normal life, according to a presenter.“We are going to talk about how we prepare our families and our kids in everyday life,” Barbara Kienzle, BSN, RN, a pediatric rheumatology nurse clinician at Augusta
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 6
ORLANDO, Fla. — Including multiple specialists to treat the various facets of systemic sclerosis improves outcomes but can have its own challenges, according to a presenter at the 2024 Rheumatology Nurses Society annual conference. “Systemic sclerosis can affect so many different organ systems, so having the various specialists all on board can be helpful,” Chad A. Hille, MD, a
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 8VIDEO: CAR T-cell therapy ‘holding up as a possible breakthrough’ in autoimmune disease - 4 day(s) ago
In this video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, calls out top stories in the July issue, including a cover story on chimeric antigen receptor T-cell therapy. “I just got back from EULAR Vienna 2024, and really the focus of that meeting, the buzz of that meeting, was on CAR T cells,” Calabrese said. “It is still holding up as a
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
🗨️"The only people who hate glucocorticoids more than rheumatologists are patients" @DrPeterMerkel @PennMedicine talks GCA and PMR management at #AWIR 2024 Keep up with Healio's coverage below 🔽 https://t.co/ydevtXtcMq https://t.co/nodrvCBmgD